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The I  (immune response) region of the mouse major histocompatibility complex codes 
for a series of lymphocyte membrane alloantigens (Ia), as well as many immunologically 
related  functions, including immune response genes, graR versus host reactivity, and 
mixed lymphocyte reactivity (1). Although there has been some controversy concerning 
the  expression  of Ia determinants  on  T  cells  (2-6),  there  is  now  agreement  that  Ia 
antigens are expressed on at least a subset of T cells,  as well as most B cells (7-12). 
We have previously shown that the simple addition of antisera directed at/-region 
determinants to either whole spleen or a splenic B-cell population will partially inhibit 
the mitogenic response to lipopolysaccharide (LPS). Since Ia is expressed on most B cells, 
it was not surprising that treatment with anti-Ia and complement can remove the ability 
of spleen cells to respond to LPS by increased thymidine incorporation (13). In contrast, 
simple  treatment  with  anti-Ia antibodies  alone,  without complement,  does not affect 
either the Concanavalin A (Con A) or phytohemagglutinin (PHA) mitogenic responses of 
spleen cell cultures.  However, removal of the Ia-positive cells from T-cell  preparations 
with anti-Ia plus rabbit complement removes Con A, but not PHA reactivity of these 
populations (11). 
Okumura et al.  have  reported  that  Ia  is  expressed  on  suppressor T  cells  (8), and 
further, Murphy et al. have shown that these determinants map in the interval between 
I-B and I-C regions in a new region designated/-J (9). The relationship between the Con 
A-reactive T cells  and suppressor T cells  is not yet clear,  but it is known that Con A 
stimulation can induce suppressor activity in spleen cell cultures (14). 
We have shown (15) that only a small portion ofT cells directly respond to Con A. This 
Ia-positive pop.ulation  can promote the mitogenic response of other Ia-negative T cells to 
Con A, hence the  name,  promotor T  cells.  The relationship  of the  Ia-positive Con A- 
responsive T cell to other previously defined T-cell subclasses described by other cellular 
alloantigens, particularly Ly or Fc determinants,  is not yet clear (16-18). 
Materials and Methods 
Mice.  All mice were raised in the breeding colonies at the University of  Southern California or 
University of Michigan. 
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Antisera.  Anti-Ia sera was produced as previously described.  Details of the donor-recipient 
combinations are given in Table I. One batch of A.TL anti-A.TH was generously provided by Dr. 
Donai Murphy. 
Antiserum  Treatments.  Cell  suspensions  were  treated  with  antiserum,  or  normal  mouse 
serum followed by complement. In brief, cells were suspended at a concentration of 10' cells/ml in a 
dilution  of antiserum  in RPMI  1640, incubated  at 37°C,  centrifuged,  resuspended  in an equal 
volume of titrated agarose-EDTA or mouse spleen cell-absorbed rabbit complement, incubated 30 
min longer, washed three times in H-3 medium without serum, and counted (11).  Dye exclusion 
microcytotoxicity tests and absorptions were performed as previously described (5). 
T-Cell Purification.  T cells were purified by filtration on nylon wool columns (19). Less than 
5% of these cell populations are Ig  + by immunofluorescence. 
Culture  Conditions.  Mitogen stimulations  were  carried  out  in  96  well Microtest II plates 
(Falcon Plastics, Oxnard, Calif.) in serum-free H-3 medium as previously described (11). Cultures 
of 5 × 105 T cells were labeled during the final 4 or 18 h with [SH]thymidine (2 Ci]mmol; 2 ~Ci/well) 
of the 72-h culture period. Cultures were harvested using a multiple sample harvester (Otto Hiller 
Co., Madison,  Wis.) and counted in a liquid scintillation counter. 
Results and Discussion 
Mapping the Ia Determinants Expressed on Promotor T  Cells.  To map the 
determinants expressed on the Con A-reactive cells to a specific portion of  the H- 
2  complex, we used a series of antisera designed to produce antibodies against 
restricted portions of  the I region of  the mouse H-2 complex. We tested a number 
of these antisera for their ability to remove promoter T-cell activity (Table I). 
Serum A.TH anti-A.TL removed the reactivity of B10.D2 T cells to Con A. This 
suggested that the cytotoxic reaction of this serum with B10.D2, which defines 
specificity Ia.7  (1), mapped the promotor activity to the I-C region. However, 
another serum [129 × B10.A(4R)]F, anti-B10.A(2R) also directed at I-C determi- 
nants  (Ia.6 and Ia.7) failed to affect the Con A response B10.A(3R) of T cells, 
although the serum does react with 3R lymph node and spleen cells in the 
microcytotoxic test. This suggested that either the Con A promotor reactivity 
mapped to the left of the B10.A(3R) crossover and failed to react in B10.A(3R), 
since it carried a portion of the H-2 b haplotype in this region, or that the [129 × 
B10.A(4R)]F,  anti-B10.A(2R) merely failed to  contain the relevant antibody, 
although it might have. Later we will present evidence that the first explana- 
tion is correct. Another antiserum (129  ×  A.TH)F~ anti-A.TL when tested on 
B10.A(4R)  targets  also fails to  affect the Con A  response,  even though it  is 
cytotoxic for B10.A(4R) lymph node and spleen cells in cytotoxic tests. These 
data map the reactivity to the D  side of the B10.A(4R) recombinant. Although 
we realize the caveats implied by negative results, both of  these observations are 
consistent with the assignment of the promotor specificity to the I-J subregion, 
between the I-B  and I-C regions. A different antiserum (A.BY ×  B10.HTT)F~, 
anti-A.TL,  when used to treat B10.A(4R) T  cells, gives similar results.  This 
antiserum  does contain  anti-I-J  reactivity  since  it  can  remove the  Con  A 
response of B10.K cells. 
In a further attempt to determine if any promotor cell specificities mapped in 
the I-A region, we tested antiserum (A × B10.D2)F, anti-B10.A(5R) on a cross- 
reactive target cell, B10.S. This reaction defines specificity Ia.9 known to map in 
the I-A  region. Although this antiserum contains antibodies reactive with H- 
2K  b specificities, no H-2  cross-reactions are known to occur with this serum 
using B10.S target cells. This antiserum has no effect on the Con A response of 
B10.S T cells after treatment with serum and complement. We also tested this FRELINGER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
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Redl~ont  Donor 
Target cell  I subregion tested  [SH]thymidine ± SD 
cpm 
A.TH  anti-A.TL  BI0.D2  I-C?  15,873  ±  3,790 
None  159,040  ±  1,463 
NMS*  60,425  --  7,377 
[129  ×  B10.A(4R)]FI  an~-B10.A(2R)  B10.A(3R)  1.E,I-C~  6L020 ±  6,903 
None  75,554  ±  4,879 
NMS  9t,688 ±  1,263 
[129  x  A.TH]F~  ardi-A.TL  B10.A(4R)  I-A  148,654  +- 3,012 
None  151,800 ±  3,554 
NM~  170,210  ±  11,096 
[A.BY × B10.I'ITI'WI  a]d~-A.TL  B10.A(4R)  I-A  72,624  ±  884 
None  63,522  ±  901 
NMS  52,666  -+ 3,239 
[A ×  B10.D2]F~  anti-B10.A(SR)  B10.S  I.A?  100,424  ±  43,644 
None  156,055 ±  18,487 
NMS  93,654  ±  39,950 
[A x  B10.D2]F1  anfi-5R absorbed with EL-4  B10  I-A  106,875  ±  25,786 
None  105,187  ±  27,771 
NMS  135,462  ±  17,271 
[A.TH x  B10.I-ITrlFI  anfi-A.TL  B10.A(9R)  lJ  3,215 ±  1,1575 
NbiS  15,543  ±  4,4925 
[A.TH x  B10.I~Tr~'~  axfli-A.TL  B10.A(5R)  IJ  3,695 ±  6205 
NMS  27,024  ±  6,0005 
[A.TH x  B10.l-lTl'~'l  anti-A.TL  B10.A(3R)  11,090  ±  1,6605 
NMS  12,950  ±  4,6785 
A.TL  anti-A.TH  B10.HTr  I-A,I-BIJ  127,364  ±  4,836 
None  123,914  ±  11,275 
NMS  121,130  ±  3,841 
* NMS, normal mouse serum. 
t  4-h label. 
serum on the homologous B10 T-cell target. David et al. have reported that the 
T-cell reactivity of blasts is considerably weaker when tested on cross-reactive 
target  cells  than homologous target  cells  (20).  To test the possibility  that we 
could detect the relevant antibody using an H-2 b target, it was necessary to first 
absorb this serum with EL-4 tumor cells to remove the anti-H-2K b antibodies. 
EL-4,  although  a  H-2 b thymic  leukemia,  does  not  appear  to  express  any  Ia 
antigens, but does express H-2K b specificities.  After this absorption, the serum 
remains cytotoxic for B10 lymph node cell targets, but not EL-4 cells. Treatment 
with this absorbed serum and complement had no effect on the Con A response 
of B10 T cells. While again a negative result, this provides further evidence that 
I-A subregion specificities such as Ia.9 are not expressed on promotor T cells for 
the Con A  response. 
The  critical  recombinants  for  mapping  the  promoter  response  are  the 
B10.HTT  and B10.S(gR) pair and the B10.A(3R)  and B10.A(5R) pair.  We pro- 
duced  an  antiserum  (A.TH  ×  B10.HTT)F1  anti-A.TL  which  should  contain 
antibodies  against  the I-A k,  I-B k,  and I-J  k  regions,  but not the I-E k  or I-C ~ 1144  FRELINGER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIG.  1.  In vitro absorption of serum (A.TH ×  B10.HTT)F1 anti-A.TL by B10.A(3R) and 
B10.A(bR).  (Top) Serum absorbed with B10.A(3R) (©--©), B10.A(bR) (A--A), or B10.HTT 
([:]--[])  spleen cells and tested against B10.A(3R) lymph node cell targets.  (Bottom)  Same 
absorbed sera tested against B10.A(bR) lymph node cell targets. 
regions.  When this serum is tested B10.S(9R) T  cells, the Con A  response is 
destroyed.  Similarly,  when tested on  B10.A(3R)  and  B10.A(bR),  there is  no 
effect on  the  B10.A(3R)  response,  but  the  B10.A(bR)  mitogenic response  is 
greatly inhibited even though B10.A(3R) and B10.A(bR) share I-A b, I-B ~, I-E k, 
and I-C a regions. These combinations together map the response to the interval 
defined  by  the  B10.A(3R)-B10.A(bR)  and  B10.S(gR)-B10.HTT  recombinant 
pairs.  Only one antiserum tested, a  single batch of A.TL anti-A.TH tested on 
B10.HTT cells, failed to show anti-promotor activity where it is expected on the 
basis of/-J-region differences. It is, of course, possible that while this antibody 
might have been present, it was merely absent from the single bleeding tested. 
As we noted earlier, other bleedings of A.TL anti-A.TH do contain anti-promo- 
tor activity (11), but none of these have been tested on B10.HTT.  It is worth- 
while to note that serum (A.TH × B10.HTT)F1 anti-A.TL reveals no detectable 
cytotoxicity when tested with B10.S(gR) lymph node or spleen cells, although it 
does kill  both  B10.D2  and B10.A  spleen  or lymph node  cells.  It  also reacts 
equally with B10.A(3R)  and B10.A(bR)  cells in cytotoxic tests. This cytotoxic 
reactivity can be explained by either anti-Ia.8 and/or anti-Ia.15 and/or Ia.22. 
However,  B10.A(3R)  and B10.A(bR)  can remove cytotoxic activity from this 
serum reciprocally (Fig.  1). Thus the specificity in the I-J region seems to be 
different from other previously defined Ia specificities. 
One point  which bears  further discussion  is  the derivation of B10.A(3R)- 
B10.A(bR) and B10.A(9R)-B10.HTT pairs in the I-J subregion. We have some 
evidence the/-3"  k and I-J  d products can cross-react. For example, A.TH anti- 
A.TL removes Con A reactivity of B10.D2 targets. This is a cross-reaction ofI-J 'l 
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B10.HTT-B10.S(9R) by ascribing the I~/region of B10.HTT to H-2 s and the I-C 
region to H-2 k. Since B10.S(gR) is derived from H-2 als recombination rather than 
H-2 tll" as in B10.HTT, the I-J region of B10.S(gR) might come from either H-2 k 
or 1-1-2  d, but just as in the B10.A(3R)-B10.A(5R) pair, the simplest explanation is 
that B10.A(3R) derives its I-J region from H-2 b, while B10.A(5R) derives its I-J 
region from H-2 k. This is the most economical explanation, since the I-E region 
of B10:S(gR), B10.HTT, B10.A(3R), and B10,A(5R) are all apparently identical 
and derived from the H-2 k hapl0type (David,: C. S. personal communication). 
In these experiments we have been unable to distinguish between I-J  d and I- 
jk, although this does not rule out that later such a distinction might be made 
with other antisera. In fact, preliminary data suggest that (C3H.Q × B10.D2)F1 
anti-AQR has such an antibody which can distinguish between I-J  d and I-J  k. 
It is surprising to note that unlike the effects of Ia sera we have reported on 
secondary Mitchell-Dutton cultures, where simple treatment of spleen cells with 
antisera directed at either the I-A  or PC subregion is sufficient to disrupt the 
secondary IgG response (21), the promotor activity is localized to only a single 
subregion of the H-2 complex. The results reported there are similar to those of 
Murphy et al. which showed that the Ia determinants expressed on the allotype 
suppressor T  cell map to a  single I  subregion (9).  Thus it may be that the Ia 
determinants are functionally segregated in specific regions rather than inter- 
spersed in the H-2 gene complex as our previous data had suggested. 
Summary 
We have shown that the Ia determinants expressed on nylon wool-purified T 
lymphocytes reactive to concanavalin A (Con A) in serum-free media are coded 
in a single I  subregion of the H-2 gene complex. This region, I-J, is defined by 
two pairs of intra-H-2  recombinant haplotypes: H-2 t3, H-2"  and H-2 ~3, H-2 t5, 
carried by B10.HTT,  B10.S(gR),  B10.A(3R),  and B10.A(SR),  respectively. No 
activity against Con A-reactive T cells has been detected in any antiserum that 
was produced in strain combinations which shared a  common I-J region. This 
suggests that Ia antigens expressed on Con A-reactive T cells are restricted to 
the I-J subregion. 
We thank Reid Toda, Weimei Chu, and Patricia Shoffner for technical assistance and Ella Morgan 
for her help in preparing this manuscript. 
Received for publication 30 June 1976. 
References 
1.  Shreffler, D. C., and C. S. David. 1975. The H-2 major histocompatibility complex and 
the I immune response region: genetic variation, function, and organization. Adv. 
Immunol. 20:125. 
2.  Hammerling, G. J., B. D. Deak, G. Mauve, U. Hammerling, and H. O. McDevitt. 
1974. 'B' lymphocyte alloantigens controlled by the I region of the major histocompat- 
ibility complex in mice. Immunogenetics.  1:68. 
3.  Sachs, D. H., and J. L. Cone. 1973. A mouse 'B' cell alloantigen determined  by gene(s) 
linked to the major histocompatibility complex. J. Exp. Med.  138:1289. 1146  FRELINGER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
4.  GStze, D. 1975. T (Iat) and B (Iab) alloantigens determined by theH-2 linked/region 
in mice. Immunogenetics.  1:495. 
5.  Frelinger, J. A., J, E. Niederhuber, C. S. David, and D. C. Shreffier. 1974. Evidence 
for the expression of Ia (H-2 associated) antigens on thymus-derived lymphocytes. J. 
Exp. Med.  140:1273. 
6.  Hauptfeld,  V.,  M.  Hauptfeld,  and J.  Klein.  1974. Tissue distribution  of/  region 
associated antigens in the mouse. J. Immunol.  113:181. 
7.  G5tze, D. 1976. Serological characterization of the H-2 k, H-2 s and H-2 q haplotypes by 
antisera produced against skin, lymphocytes, and lymphoblasts. Strain distribution 
pattern of Ia antigens and their relationship to Ir genes. Immunogenetics.  3:139. 
8.  Okumura, K., L. A. Herzenberg, D. B. Murphy, H. O. McDevitt, and L. A. Herzen- 
berg. Selective expression of H-2  (I region) loci controlling determinants on helper 
and suppressor T lymphocytes. J. Exp. Med.  144:685. 
9.  Murphy,  D.  B.,  L.  A.  Herzenberg,  K.  Okumura,  L.  A.  Herzenberg,  and  H.  O. 
McDevitt.  A  new I  subregion  (/-J)  marked by a  locus  (Ia-4)  controlling surface 
determinants on suppressor T cells. J. Exp. Med.  144:699. 
10.  Plate, J. M. D. 1976. Cellular respenses to murine alloantigens of  the major histocom- 
patibility complex. The role of  cell subpopulations that express different quantities of 
H-2 associated antigenic markers. Eur. J. Immunol.  6:180. 
11.  Niederhuber, J.  E., J. A. Frelinger, M.  S.  Dine, P. Shoffner, E. Dugan, and D. C. 
Shreffler. 1976. Effects ofanti-Ia sera on mitogenic responses. II. Differential expres- 
sion of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J. 
Exp. Med.  143:372. 
12.  Fathman,  G. C., J.  L.  Cone, S.  O.  Sharrow,  H. Tyrer, and D.  H. Sachs.  1975. Ia 
alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. 
J. Immunol.  115:584. 
13.  Niederhuber,, J.  E., J.  A.  Frelinger,  E.  Dugan, A.  Coutinho,  and D.  C.  Shreffier. 
1975. Effects of anti-Ia serum on mitogenic responses. I. Inhibition of  the proliferative 
response to B-cell mitogen, LPS by specific anti-Ia sera. J. Immunol.  115:1672. 
14.  Rich, R. R., and C. W. Pierce. 1973. Biological expression of lymphocyte activation. 
II.  Generation of a  population of thymus-derived suppressor lymphocytes. J. Exp. 
Med.  137:639. 
15.  Frelinger, J. A., and J. E. Niederhuber. 1976. Recruitment ofIa  T cell by Ia  ÷ T cells 
in the response to Con A. Fed. Proc. 35:352. 
16.  Stout,  R.  D.,  and  L.  A.  Herzenberg.  1975. The  Fc  receptor  or  thymus-derived 
lymphocytes. II. Mitogen responsiveness of T lymphocytes bearing the Fc receptor. J. 
Exp. Med.  142:1041. 
17.  Hirst, J. A., P. C. L. Beverly, P. Kisielow, M. K. Hoffrnan, and H. F. Oettgen. 1975. 
Ly antigens: markers ofT-cell function on mouse spleen cells. J. Immunol.  115:1555. 
18.  Jandinski,  J.,  H.  Cantor,  T.  Tadakuma,  D.  L.  Peavy,  and  C.  W.  Pierce.  1976. 
Separation of helper T cells from suppressor T cells expressing different Ly compo- 
nents° I. Polyclonal activation: suppressor and helper activities are inherent proper- 
ties of distinct T-cell subclasses. J. Exp. Med.  143:1382. 
19.  Julius,  M.  H.,  E.  Simpson,  and  L.  A.  Herzenberg.  1973. A  rapid method for the 
isolation of functional thymus derived murine lymphocytes. Eur. J. Immunol. 3:645. 
20.  David, C., T. Meo, J. McCormick, and D. Shreffier. 1976. Expression of individual Ia 
specificities on T  and B  cells.  I. Studies with mitogen-induced blast cells. J. Exp. 
Med.  143:218. 
21.  Niederhuber, J. E., and J. A. Frelinger. 1976. Ia antigens and their role in immune 
responses. Transplant. Rev. 30:101. 